
VR Adviser, LLC is a Venture Capital based in New York, NY led by Jessica Tong Baron, reporting $3.3B in AUM as of Q3 2025 with 75% Healthcare concentration, 69% concentrated in top 10 holdings, and 19% allocation to APGE.
Largest long holdings in VR Adviser, LLC's portfolio (69% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $337.4M | 18.99% | — | 14.25% 8.5M shares | |
Unknown Unknown | $196.3M | 11.05% | — | 3.56% 3.8M shares | |
Biotechnology Healthcare | $153.9M | 8.66% | +$4.7M Bought | 7.56% 13.2M shares | |
Biotechnology Healthcare | $90.7M | 5.10% | +$29.5M Bought | 3.73% 946.8K shares | |
Biotechnology Healthcare | $83.8M | 4.72% | — | 4.75% 3.9M shares | |
Biotechnology Healthcare | $82.0M | 4.61% | — | 13.32% 6.7M shares | |
Unknown Unknown | $79.8M | 4.49% | — | 8.57% 4.1M shares | |
Biotechnology Healthcare | $79.2M | 4.46% | — | 6.79% 6.6M shares | |
Biotechnology Healthcare | $66.0M | 3.72% | -$16.4M Sold | 5.45% 3.2M shares | |
Biotechnology Healthcare | $57.4M | 3.23% | -$10.8M Sold | 2.86% 4.0M shares |
Portfolio activity, position movements, and quarter-over-quarter changes in VR Adviser, LLC's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
+344.09% | |
+48.15% | |
+42.74% |
| Position | Shares Δ |
|---|---|
-67.05% | |
-57.15% | |
-49.06% | |
-19.87% | |
-15.89% |
Portfolio insights and performance metrics for VR Adviser, LLC
We use cookies for analytics. See our Privacy and Cookie Policy.